Author:
Lee Jae Jin,Extermann Martine
Reference86 articles.
1. Howlader N NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) SEER cancer statistics review, 1975–2012. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2012/ , Apr 2015
2. Extermann M, Overcash J, Lyman GH et al (1998) Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16:1582–1587
3. Extermann M (2000) Measuring comorbidity in older cancer patients. Eur J Cancer 36:453–471
4. Extermann M (2000) Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 35:181–200
5. Anderson G, Kerluke K (1996) Distribution of prescription drug exposures in the elderly: description and implications. J Clin Epidemiol 49:929–935